nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP3A4—breast cancer	0.161	0.546	CbGaD
Sitagliptin—ABCB1—breast cancer	0.134	0.454	CbGaD
Sitagliptin—CYP2C8—Lapatinib—breast cancer	0.0354	0.0756	CbGbCtD
Sitagliptin—ABCB1—Toremifene—breast cancer	0.0329	0.0702	CbGbCtD
Sitagliptin—CYP3A4—Exemestane—breast cancer	0.0284	0.0607	CbGbCtD
Sitagliptin—CYP2C8—Raloxifene—breast cancer	0.0268	0.0573	CbGbCtD
Sitagliptin—CYP3A4—Letrozole—breast cancer	0.0241	0.0516	CbGbCtD
Sitagliptin—ABCB1—Lapatinib—breast cancer	0.024	0.0512	CbGbCtD
Sitagliptin—CYP3A4—Anastrozole—breast cancer	0.0215	0.046	CbGbCtD
Sitagliptin—CYP3A4—Toremifene—breast cancer	0.0197	0.0421	CbGbCtD
Sitagliptin—CYP3A4—Fulvestrant—breast cancer	0.0183	0.0391	CbGbCtD
Sitagliptin—CYP2C8—Tamoxifen—breast cancer	0.0177	0.0379	CbGbCtD
Sitagliptin—CYP3A4—Thiotepa—breast cancer	0.0163	0.0348	CbGbCtD
Sitagliptin—CYP3A4—Ixabepilone—breast cancer	0.0149	0.0319	CbGbCtD
Sitagliptin—CYP3A4—Lapatinib—breast cancer	0.0144	0.0307	CbGbCtD
Sitagliptin—CYP2C8—Paclitaxel—breast cancer	0.0138	0.0295	CbGbCtD
Sitagliptin—ABCB1—Vinorelbine—breast cancer	0.0133	0.0284	CbGbCtD
Sitagliptin—CYP2C8—Fluorouracil—breast cancer	0.0131	0.0279	CbGbCtD
Sitagliptin—ABCB1—Tamoxifen—breast cancer	0.012	0.0256	CbGbCtD
Sitagliptin—ABCB1—Mitoxantrone—breast cancer	0.0117	0.025	CbGbCtD
Sitagliptin—CYP3A4—Raloxifene—breast cancer	0.0109	0.0232	CbGbCtD
Sitagliptin—ABCB1—Gemcitabine—breast cancer	0.0103	0.0221	CbGbCtD
Sitagliptin—ABCB1—Paclitaxel—breast cancer	0.00934	0.02	CbGbCtD
Sitagliptin—ABCB1—Irinotecan—breast cancer	0.00922	0.0197	CbGbCtD
Sitagliptin—ABCB1—Vinblastine—breast cancer	0.00819	0.0175	CbGbCtD
Sitagliptin—CYP3A4—Vinorelbine—breast cancer	0.00797	0.017	CbGbCtD
Sitagliptin—CYP3A4—Tamoxifen—breast cancer	0.00719	0.0154	CbGbCtD
Sitagliptin—CYP3A4—Mitoxantrone—breast cancer	0.00701	0.015	CbGbCtD
Sitagliptin—ABCB1—Docetaxel—breast cancer	0.00675	0.0144	CbGbCtD
Sitagliptin—CYP3A4—Paclitaxel—breast cancer	0.0056	0.012	CbGbCtD
Sitagliptin—CYP3A4—Irinotecan—breast cancer	0.00552	0.0118	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—breast cancer	0.00503	0.0108	CbGbCtD
Sitagliptin—CYP3A4—Vinblastine—breast cancer	0.00491	0.0105	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—breast cancer	0.00488	0.0104	CbGbCtD
Sitagliptin—CYP3A4—Docetaxel—breast cancer	0.00405	0.00864	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—breast cancer	0.00302	0.00644	CbGbCtD
Sitagliptin—DPP4—embryo—breast cancer	0.00106	0.0898	CbGeAlD
Sitagliptin—DPP4—epithelium—breast cancer	0.000865	0.0733	CbGeAlD
Sitagliptin—DPP4—endometrium—breast cancer	0.000776	0.0657	CbGeAlD
Sitagliptin—CYP2C8—mammary gland—breast cancer	0.000748	0.0633	CbGeAlD
Sitagliptin—DPP4—uterus—breast cancer	0.000715	0.0606	CbGeAlD
Sitagliptin—DPP4—adipose tissue—breast cancer	0.000699	0.0592	CbGeAlD
Sitagliptin—DPP4—female reproductive system—breast cancer	0.000643	0.0544	CbGeAlD
Sitagliptin—DPP4—adrenal gland—breast cancer	0.000627	0.0531	CbGeAlD
Sitagliptin—DPP4—bone marrow—breast cancer	0.000607	0.0514	CbGeAlD
Sitagliptin—DPP4—female gonad—breast cancer	0.000585	0.0495	CbGeAlD
Sitagliptin—DPP4—endocrine gland—breast cancer	0.000544	0.0461	CbGeAlD
Sitagliptin—DPP4—lymph node—breast cancer	0.000376	0.0318	CbGeAlD
Sitagliptin—CYP2C8—endometrium—breast cancer	0.000374	0.0316	CbGeAlD
Sitagliptin—CYP2C8—pituitary gland—breast cancer	0.000338	0.0286	CbGeAlD
Sitagliptin—CYP2C8—female reproductive system—breast cancer	0.000309	0.0262	CbGeAlD
Sitagliptin—CYP2C8—endocrine gland—breast cancer	0.000262	0.0222	CbGeAlD
Sitagliptin—ABCB1—embryo—breast cancer	0.000245	0.0207	CbGeAlD
Sitagliptin—CYP3A4—female reproductive system—breast cancer	0.00021	0.0178	CbGeAlD
Sitagliptin—ABCB1—epithelium—breast cancer	0.0002	0.0169	CbGeAlD
Sitagliptin—ABCB1—endometrium—breast cancer	0.000179	0.0152	CbGeAlD
Sitagliptin—CYP3A4—endocrine gland—breast cancer	0.000177	0.015	CbGeAlD
Sitagliptin—ABCB1—uterus—breast cancer	0.000165	0.014	CbGeAlD
Sitagliptin—ABCB1—pituitary gland—breast cancer	0.000162	0.0137	CbGeAlD
Sitagliptin—ABCB1—adipose tissue—breast cancer	0.000161	0.0137	CbGeAlD
Sitagliptin—ABCB1—female reproductive system—breast cancer	0.000148	0.0126	CbGeAlD
Sitagliptin—ABCB1—adrenal gland—breast cancer	0.000145	0.0123	CbGeAlD
Sitagliptin—ABCB1—bone marrow—breast cancer	0.00014	0.0119	CbGeAlD
Sitagliptin—ABCB1—female gonad—breast cancer	0.000135	0.0114	CbGeAlD
Sitagliptin—ABCB1—endocrine gland—breast cancer	0.000126	0.0106	CbGeAlD
Sitagliptin—ABCB1—lymph node—breast cancer	8.68e-05	0.00735	CbGeAlD
Sitagliptin—Pneumonia—Doxorubicin—breast cancer	5.49e-05	0.000305	CcSEcCtD
Sitagliptin—Nervous system disorder—Docetaxel—breast cancer	5.47e-05	0.000304	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—breast cancer	5.46e-05	0.000303	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—breast cancer	5.46e-05	0.000303	CcSEcCtD
Sitagliptin—Feeling abnormal—Paclitaxel—breast cancer	5.42e-05	0.000301	CcSEcCtD
Sitagliptin—Skin disorder—Docetaxel—breast cancer	5.42e-05	0.000301	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.41e-05	0.000301	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Paclitaxel—breast cancer	5.38e-05	0.000299	CcSEcCtD
Sitagliptin—Diarrhoea—Gemcitabine—breast cancer	5.38e-05	0.000299	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—breast cancer	5.36e-05	0.000298	CcSEcCtD
Sitagliptin—Infection—Capecitabine—breast cancer	5.36e-05	0.000298	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—breast cancer	5.35e-05	0.000297	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—breast cancer	5.35e-05	0.000297	CcSEcCtD
Sitagliptin—Dizziness—Irinotecan—breast cancer	5.33e-05	0.000297	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—breast cancer	5.3e-05	0.000295	CcSEcCtD
Sitagliptin—Nervous system disorder—Capecitabine—breast cancer	5.29e-05	0.000294	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—breast cancer	5.29e-05	0.000294	CcSEcCtD
Sitagliptin—Diarrhoea—Fluorouracil—breast cancer	5.29e-05	0.000294	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—breast cancer	5.27e-05	0.000293	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—breast cancer	5.25e-05	0.000292	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—breast cancer	5.25e-05	0.000292	CcSEcCtD
Sitagliptin—Skin disorder—Capecitabine—breast cancer	5.24e-05	0.000292	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—breast cancer	5.23e-05	0.000291	CcSEcCtD
Sitagliptin—Urticaria—Paclitaxel—breast cancer	5.23e-05	0.000291	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—breast cancer	5.22e-05	0.00029	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—breast cancer	5.2e-05	0.000289	CcSEcCtD
Sitagliptin—Abdominal pain—Paclitaxel—breast cancer	5.2e-05	0.000289	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—breast cancer	5.19e-05	0.000288	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—breast cancer	5.16e-05	0.000287	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—breast cancer	5.13e-05	0.000285	CcSEcCtD
Sitagliptin—Vomiting—Mitoxantrone—breast cancer	5.13e-05	0.000285	CcSEcCtD
Sitagliptin—Vomiting—Irinotecan—breast cancer	5.13e-05	0.000285	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—breast cancer	5.12e-05	0.000285	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—breast cancer	5.11e-05	0.000284	CcSEcCtD
Sitagliptin—Dizziness—Fluorouracil—breast cancer	5.11e-05	0.000284	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—breast cancer	5.1e-05	0.000283	CcSEcCtD
Sitagliptin—Rash—Irinotecan—breast cancer	5.09e-05	0.000283	CcSEcCtD
Sitagliptin—Rash—Mitoxantrone—breast cancer	5.09e-05	0.000283	CcSEcCtD
Sitagliptin—Dermatitis—Mitoxantrone—breast cancer	5.08e-05	0.000282	CcSEcCtD
Sitagliptin—Dermatitis—Irinotecan—breast cancer	5.08e-05	0.000282	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Docetaxel—breast cancer	5.08e-05	0.000282	CcSEcCtD
Sitagliptin—Headache—Irinotecan—breast cancer	5.05e-05	0.000281	CcSEcCtD
Sitagliptin—Headache—Mitoxantrone—breast cancer	5.05e-05	0.000281	CcSEcCtD
Sitagliptin—Insomnia—Docetaxel—breast cancer	5.04e-05	0.00028	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—breast cancer	5.01e-05	0.000278	CcSEcCtD
Sitagliptin—Vomiting—Gemcitabine—breast cancer	5e-05	0.000278	CcSEcCtD
Sitagliptin—Somnolence—Docetaxel—breast cancer	4.96e-05	0.000276	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—breast cancer	4.96e-05	0.000276	CcSEcCtD
Sitagliptin—Rash—Gemcitabine—breast cancer	4.95e-05	0.000275	CcSEcCtD
Sitagliptin—Dermatitis—Gemcitabine—breast cancer	4.95e-05	0.000275	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—breast cancer	4.95e-05	0.000275	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—breast cancer	4.92e-05	0.000274	CcSEcCtD
Sitagliptin—Headache—Gemcitabine—breast cancer	4.92e-05	0.000274	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Capecitabine—breast cancer	4.92e-05	0.000273	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—breast cancer	4.91e-05	0.000273	CcSEcCtD
Sitagliptin—Vomiting—Fluorouracil—breast cancer	4.91e-05	0.000273	CcSEcCtD
Sitagliptin—Dyspepsia—Docetaxel—breast cancer	4.91e-05	0.000273	CcSEcCtD
Sitagliptin—Insomnia—Capecitabine—breast cancer	4.88e-05	0.000271	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—breast cancer	4.87e-05	0.000271	CcSEcCtD
Sitagliptin—Rash—Fluorouracil—breast cancer	4.87e-05	0.000271	CcSEcCtD
Sitagliptin—Dermatitis—Fluorouracil—breast cancer	4.87e-05	0.000271	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—breast cancer	4.86e-05	0.00027	CcSEcCtD
Sitagliptin—Decreased appetite—Docetaxel—breast cancer	4.85e-05	0.000269	CcSEcCtD
Sitagliptin—Hypersensitivity—Paclitaxel—breast cancer	4.85e-05	0.000269	CcSEcCtD
Sitagliptin—Headache—Fluorouracil—breast cancer	4.84e-05	0.000269	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—breast cancer	4.84e-05	0.000269	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—breast cancer	4.83e-05	0.000268	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Docetaxel—breast cancer	4.81e-05	0.000268	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—breast cancer	4.81e-05	0.000268	CcSEcCtD
Sitagliptin—Fatigue—Docetaxel—breast cancer	4.81e-05	0.000267	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—breast cancer	4.8e-05	0.000267	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—breast cancer	4.8e-05	0.000267	CcSEcCtD
Sitagliptin—Nausea—Irinotecan—breast cancer	4.79e-05	0.000266	CcSEcCtD
Sitagliptin—Nausea—Mitoxantrone—breast cancer	4.79e-05	0.000266	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—breast cancer	4.78e-05	0.000266	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—breast cancer	4.77e-05	0.000265	CcSEcCtD
Sitagliptin—Pain—Docetaxel—breast cancer	4.77e-05	0.000265	CcSEcCtD
Sitagliptin—Constipation—Docetaxel—breast cancer	4.77e-05	0.000265	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—breast cancer	4.76e-05	0.000265	CcSEcCtD
Sitagliptin—Dyspepsia—Capecitabine—breast cancer	4.75e-05	0.000264	CcSEcCtD
Sitagliptin—Asthenia—Paclitaxel—breast cancer	4.72e-05	0.000262	CcSEcCtD
Sitagliptin—Decreased appetite—Capecitabine—breast cancer	4.69e-05	0.000261	CcSEcCtD
Sitagliptin—Nausea—Gemcitabine—breast cancer	4.67e-05	0.000259	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Capecitabine—breast cancer	4.66e-05	0.000259	CcSEcCtD
Sitagliptin—Fatigue—Capecitabine—breast cancer	4.65e-05	0.000259	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—breast cancer	4.64e-05	0.000258	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—breast cancer	4.64e-05	0.000258	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—breast cancer	4.63e-05	0.000257	CcSEcCtD
Sitagliptin—Constipation—Capecitabine—breast cancer	4.62e-05	0.000257	CcSEcCtD
Sitagliptin—Pain—Capecitabine—breast cancer	4.62e-05	0.000257	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—breast cancer	4.61e-05	0.000256	CcSEcCtD
Sitagliptin—Feeling abnormal—Docetaxel—breast cancer	4.6e-05	0.000255	CcSEcCtD
Sitagliptin—Nausea—Fluorouracil—breast cancer	4.59e-05	0.000255	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—breast cancer	4.58e-05	0.000254	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—breast cancer	4.57e-05	0.000254	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Docetaxel—breast cancer	4.56e-05	0.000253	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—breast cancer	4.55e-05	0.000253	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—breast cancer	4.54e-05	0.000252	CcSEcCtD
Sitagliptin—Tension—Epirubicin—breast cancer	4.52e-05	0.000251	CcSEcCtD
Sitagliptin—Diarrhoea—Paclitaxel—breast cancer	4.5e-05	0.00025	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—breast cancer	4.48e-05	0.000249	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—breast cancer	4.46e-05	0.000248	CcSEcCtD
Sitagliptin—Feeling abnormal—Capecitabine—breast cancer	4.45e-05	0.000247	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—breast cancer	4.44e-05	0.000247	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—breast cancer	4.44e-05	0.000247	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—breast cancer	4.43e-05	0.000246	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—breast cancer	4.42e-05	0.000246	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—breast cancer	4.42e-05	0.000246	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Capecitabine—breast cancer	4.41e-05	0.000245	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—breast cancer	4.41e-05	0.000245	CcSEcCtD
Sitagliptin—Abdominal pain—Docetaxel—breast cancer	4.41e-05	0.000245	CcSEcCtD
Sitagliptin—Dizziness—Paclitaxel—breast cancer	4.35e-05	0.000242	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—breast cancer	4.34e-05	0.000241	CcSEcCtD
Sitagliptin—Cough—Methotrexate—breast cancer	4.3e-05	0.000239	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—breast cancer	4.29e-05	0.000239	CcSEcCtD
Sitagliptin—Urticaria—Capecitabine—breast cancer	4.29e-05	0.000238	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—breast cancer	4.28e-05	0.000238	CcSEcCtD
Sitagliptin—Abdominal pain—Capecitabine—breast cancer	4.27e-05	0.000237	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—breast cancer	4.26e-05	0.000237	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—breast cancer	4.2e-05	0.000234	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—breast cancer	4.19e-05	0.000233	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—breast cancer	4.19e-05	0.000233	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—breast cancer	4.18e-05	0.000233	CcSEcCtD
Sitagliptin—Vomiting—Paclitaxel—breast cancer	4.18e-05	0.000233	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.16e-05	0.000231	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—breast cancer	4.16e-05	0.000231	CcSEcCtD
Sitagliptin—Rash—Paclitaxel—breast cancer	4.15e-05	0.000231	CcSEcCtD
Sitagliptin—Dermatitis—Paclitaxel—breast cancer	4.14e-05	0.00023	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—breast cancer	4.14e-05	0.00023	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—breast cancer	4.14e-05	0.00023	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—breast cancer	4.14e-05	0.00023	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—breast cancer	4.12e-05	0.000229	CcSEcCtD
Sitagliptin—Headache—Paclitaxel—breast cancer	4.12e-05	0.000229	CcSEcCtD
Sitagliptin—Hypersensitivity—Docetaxel—breast cancer	4.11e-05	0.000228	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—breast cancer	4.1e-05	0.000228	CcSEcCtD
Sitagliptin—Cough—Epirubicin—breast cancer	4.02e-05	0.000224	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—breast cancer	4.02e-05	0.000223	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—breast cancer	4.02e-05	0.000223	CcSEcCtD
Sitagliptin—Asthenia—Docetaxel—breast cancer	4e-05	0.000222	CcSEcCtD
Sitagliptin—Infection—Methotrexate—breast cancer	3.99e-05	0.000222	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—breast cancer	3.98e-05	0.000221	CcSEcCtD
Sitagliptin—Hypersensitivity—Capecitabine—breast cancer	3.98e-05	0.000221	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—breast cancer	3.96e-05	0.00022	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—breast cancer	3.94e-05	0.000219	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—breast cancer	3.92e-05	0.000218	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—breast cancer	3.92e-05	0.000218	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—breast cancer	3.91e-05	0.000217	CcSEcCtD
Sitagliptin—Nausea—Paclitaxel—breast cancer	3.91e-05	0.000217	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—breast cancer	3.9e-05	0.000217	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.9e-05	0.000217	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—breast cancer	3.88e-05	0.000216	CcSEcCtD
Sitagliptin—Asthenia—Capecitabine—breast cancer	3.87e-05	0.000215	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—breast cancer	3.85e-05	0.000214	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—breast cancer	3.84e-05	0.000213	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—breast cancer	3.83e-05	0.000213	CcSEcCtD
Sitagliptin—Diarrhoea—Docetaxel—breast cancer	3.82e-05	0.000212	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—breast cancer	3.76e-05	0.000209	CcSEcCtD
Sitagliptin—Infection—Epirubicin—breast cancer	3.74e-05	0.000208	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—breast cancer	3.72e-05	0.000207	CcSEcCtD
Sitagliptin—Diarrhoea—Capecitabine—breast cancer	3.69e-05	0.000205	CcSEcCtD
Sitagliptin—Nervous system disorder—Epirubicin—breast cancer	3.69e-05	0.000205	CcSEcCtD
Sitagliptin—Dizziness—Docetaxel—breast cancer	3.69e-05	0.000205	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—breast cancer	3.68e-05	0.000205	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—breast cancer	3.66e-05	0.000204	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—breast cancer	3.65e-05	0.000203	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—breast cancer	3.64e-05	0.000202	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—breast cancer	3.63e-05	0.000202	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—breast cancer	3.63e-05	0.000202	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—breast cancer	3.62e-05	0.000201	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.61e-05	0.0002	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—breast cancer	3.59e-05	0.000199	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—breast cancer	3.57e-05	0.000199	CcSEcCtD
Sitagliptin—Dizziness—Capecitabine—breast cancer	3.57e-05	0.000198	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—breast cancer	3.55e-05	0.000197	CcSEcCtD
Sitagliptin—Vomiting—Docetaxel—breast cancer	3.55e-05	0.000197	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—breast cancer	3.54e-05	0.000197	CcSEcCtD
Sitagliptin—Rash—Docetaxel—breast cancer	3.52e-05	0.000195	CcSEcCtD
Sitagliptin—Dermatitis—Docetaxel—breast cancer	3.51e-05	0.000195	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—breast cancer	3.49e-05	0.000194	CcSEcCtD
Sitagliptin—Headache—Docetaxel—breast cancer	3.49e-05	0.000194	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—breast cancer	3.48e-05	0.000193	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—breast cancer	3.47e-05	0.000193	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—breast cancer	3.47e-05	0.000193	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—breast cancer	3.46e-05	0.000192	CcSEcCtD
Sitagliptin—Pain—Methotrexate—breast cancer	3.44e-05	0.000191	CcSEcCtD
Sitagliptin—Vomiting—Capecitabine—breast cancer	3.43e-05	0.000191	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—breast cancer	3.43e-05	0.00019	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—breast cancer	3.41e-05	0.00019	CcSEcCtD
Sitagliptin—Rash—Capecitabine—breast cancer	3.4e-05	0.000189	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—breast cancer	3.4e-05	0.000189	CcSEcCtD
Sitagliptin—Dermatitis—Capecitabine—breast cancer	3.4e-05	0.000189	CcSEcCtD
Sitagliptin—Headache—Capecitabine—breast cancer	3.38e-05	0.000188	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—breast cancer	3.38e-05	0.000188	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—breast cancer	3.34e-05	0.000186	CcSEcCtD
Sitagliptin—Nausea—Docetaxel—breast cancer	3.31e-05	0.000184	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—breast cancer	3.31e-05	0.000184	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—breast cancer	3.31e-05	0.000184	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—breast cancer	3.29e-05	0.000183	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—breast cancer	3.27e-05	0.000182	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—breast cancer	3.25e-05	0.000181	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—breast cancer	3.24e-05	0.00018	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—breast cancer	3.22e-05	0.000179	CcSEcCtD
Sitagliptin—Pain—Epirubicin—breast cancer	3.22e-05	0.000179	CcSEcCtD
Sitagliptin—Nausea—Capecitabine—breast cancer	3.21e-05	0.000178	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—breast cancer	3.19e-05	0.000177	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—breast cancer	3.18e-05	0.000177	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.17e-05	0.000176	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—breast cancer	3.15e-05	0.000175	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—breast cancer	3.1e-05	0.000172	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—breast cancer	3.09e-05	0.000172	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—breast cancer	3.08e-05	0.000171	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—breast cancer	3.06e-05	0.00017	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—breast cancer	3.03e-05	0.000168	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—breast cancer	3e-05	0.000167	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—breast cancer	3e-05	0.000167	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—breast cancer	2.99e-05	0.000166	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—breast cancer	2.98e-05	0.000165	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—breast cancer	2.98e-05	0.000165	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—breast cancer	2.97e-05	0.000165	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—breast cancer	2.96e-05	0.000165	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—breast cancer	2.88e-05	0.00016	CcSEcCtD
Sitagliptin—Feeling abnormal—Doxorubicin—breast cancer	2.87e-05	0.000159	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—breast cancer	2.85e-05	0.000158	CcSEcCtD
Sitagliptin—Hypersensitivity—Epirubicin—breast cancer	2.77e-05	0.000154	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—breast cancer	2.76e-05	0.000154	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—breast cancer	2.75e-05	0.000153	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—breast cancer	2.75e-05	0.000153	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—breast cancer	2.7e-05	0.00015	CcSEcCtD
Sitagliptin—Dizziness—Methotrexate—breast cancer	2.66e-05	0.000148	CcSEcCtD
Sitagliptin—Diarrhoea—Epirubicin—breast cancer	2.57e-05	0.000143	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—breast cancer	2.56e-05	0.000143	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—breast cancer	2.56e-05	0.000142	CcSEcCtD
Sitagliptin—Rash—Methotrexate—breast cancer	2.53e-05	0.000141	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—breast cancer	2.53e-05	0.000141	CcSEcCtD
Sitagliptin—Headache—Methotrexate—breast cancer	2.52e-05	0.00014	CcSEcCtD
Sitagliptin—Asthenia—Doxorubicin—breast cancer	2.5e-05	0.000139	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—breast cancer	2.49e-05	0.000138	CcSEcCtD
Sitagliptin—Vomiting—Epirubicin—breast cancer	2.39e-05	0.000133	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—breast cancer	2.39e-05	0.000133	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—breast cancer	2.38e-05	0.000132	CcSEcCtD
Sitagliptin—Rash—Epirubicin—breast cancer	2.37e-05	0.000132	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—breast cancer	2.37e-05	0.000132	CcSEcCtD
Sitagliptin—Headache—Epirubicin—breast cancer	2.36e-05	0.000131	CcSEcCtD
Sitagliptin—Dizziness—Doxorubicin—breast cancer	2.3e-05	0.000128	CcSEcCtD
Sitagliptin—Nausea—Epirubicin—breast cancer	2.23e-05	0.000124	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—breast cancer	2.21e-05	0.000123	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—breast cancer	2.19e-05	0.000122	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—breast cancer	2.19e-05	0.000122	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—breast cancer	2.18e-05	0.000121	CcSEcCtD
Sitagliptin—Nausea—Doxorubicin—breast cancer	2.07e-05	0.000115	CcSEcCtD
Sitagliptin—ABCB1—Metabolism—ALDH1A1—breast cancer	1.25e-05	0.000273	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDH7A1—breast cancer	1.25e-05	0.000273	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	1.24e-05	0.000271	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARGC1B—breast cancer	1.24e-05	0.000271	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	1.23e-05	0.00027	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	1.21e-05	0.000264	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.2e-05	0.000263	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.2e-05	0.000263	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FHL2—breast cancer	1.2e-05	0.000262	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ADSL—breast cancer	1.2e-05	0.000262	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—UMPS—breast cancer	1.2e-05	0.000262	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PHGDH—breast cancer	1.2e-05	0.000262	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NME1—breast cancer	1.2e-05	0.000262	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NDUFS3—breast cancer	1.19e-05	0.000261	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.19e-05	0.00026	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HPSE—breast cancer	1.17e-05	0.000257	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—LDHB—breast cancer	1.17e-05	0.000257	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BRIP1—breast cancer	1.17e-05	0.000257	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTA4—breast cancer	1.17e-05	0.000256	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA9—breast cancer	1.17e-05	0.000256	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	1.16e-05	0.000254	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.15e-05	0.000252	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.15e-05	0.000251	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.14e-05	0.00025	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPX2—breast cancer	1.14e-05	0.000249	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTA2—breast cancer	1.14e-05	0.000249	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPX4—breast cancer	1.12e-05	0.000246	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SULT1A1—breast cancer	1.12e-05	0.000246	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CHST9—breast cancer	1.12e-05	0.000245	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.12e-05	0.000244	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ABCC1—breast cancer	1.11e-05	0.000243	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA3—breast cancer	1.11e-05	0.000243	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMMR—breast cancer	1.11e-05	0.000243	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTA1—breast cancer	1.1e-05	0.00024	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—IDH1—breast cancer	1.1e-05	0.00024	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NAT2—breast cancer	1.09e-05	0.000238	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARGC1B—breast cancer	1.08e-05	0.000236	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.07e-05	0.000234	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—COX11—breast cancer	1.06e-05	0.000233	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.06e-05	0.000231	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.03e-05	0.000225	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.02e-05	0.000224	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA4—breast cancer	1.02e-05	0.000223	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA9—breast cancer	1.02e-05	0.000223	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1e-05	0.00022	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA2—breast cancer	9.91e-06	0.000217	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPX2—breast cancer	9.91e-06	0.000217	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.81e-06	0.000215	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SULT1A1—breast cancer	9.79e-06	0.000214	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPX4—breast cancer	9.79e-06	0.000214	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CDA—breast cancer	9.73e-06	0.000213	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SHMT1—breast cancer	9.73e-06	0.000213	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTA1—breast cancer	9.56e-06	0.000209	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—IDH1—breast cancer	9.56e-06	0.000209	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	9.56e-06	0.000209	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—DPYD—breast cancer	9.52e-06	0.000208	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MED12—breast cancer	9.52e-06	0.000208	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	9.48e-06	0.000207	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NAT2—breast cancer	9.46e-06	0.000207	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALDOA—breast cancer	9.37e-06	0.000205	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLCO1B1—breast cancer	9.36e-06	0.000205	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC2A5—breast cancer	9.36e-06	0.000205	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOA3—breast cancer	9.1e-06	0.000199	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—APRT—breast cancer	9.04e-06	0.000198	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC2A2—breast cancer	9.03e-06	0.000198	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.94e-06	0.000196	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCG2—breast cancer	8.85e-06	0.000194	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTR—breast cancer	8.85e-06	0.000194	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CPT1A—breast cancer	8.85e-06	0.000194	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	8.71e-06	0.000191	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HPGDS—breast cancer	8.68e-06	0.00019	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HBA1—breast cancer	8.62e-06	0.000189	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ESRRA—breast cancer	8.5e-06	0.000186	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ANGPTL4—breast cancer	8.5e-06	0.000186	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.43e-06	0.000184	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ACHE—breast cancer	8.42e-06	0.000184	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTT1—breast cancer	8.42e-06	0.000184	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—DPYD—breast cancer	8.29e-06	0.000181	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MED12—breast cancer	8.29e-06	0.000181	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALDOA—breast cancer	8.16e-06	0.000179	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPI—breast cancer	8.06e-06	0.000176	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HADHB—breast cancer	8.06e-06	0.000176	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP17A1—breast cancer	7.97e-06	0.000174	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOA3—breast cancer	7.92e-06	0.000173	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS1—breast cancer	7.89e-06	0.000173	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ENO1—breast cancer	7.89e-06	0.000173	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC2A2—breast cancer	7.87e-06	0.000172	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.86e-06	0.000172	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.76e-06	0.00017	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP2D6—breast cancer	7.73e-06	0.000169	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ABCG2—breast cancer	7.71e-06	0.000169	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CPT1A—breast cancer	7.71e-06	0.000169	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTR—breast cancer	7.71e-06	0.000169	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDH7A1—breast cancer	7.69e-06	0.000168	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDH1A1—breast cancer	7.69e-06	0.000168	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOA2—breast cancer	7.59e-06	0.000166	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HPGDS—breast cancer	7.56e-06	0.000165	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HBA1—breast cancer	7.51e-06	0.000164	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NME1—breast cancer	7.37e-06	0.000161	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ADSL—breast cancer	7.37e-06	0.000161	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—UMPS—breast cancer	7.37e-06	0.000161	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PHGDH—breast cancer	7.37e-06	0.000161	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FHL2—breast cancer	7.37e-06	0.000161	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—FASN—breast cancer	7.36e-06	0.000161	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTT1—breast cancer	7.33e-06	0.00016	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ACHE—breast cancer	7.33e-06	0.00016	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—BCHE—breast cancer	7.33e-06	0.00016	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC5A5—breast cancer	7.24e-06	0.000158	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—LDHB—breast cancer	7.23e-06	0.000158	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HPSE—breast cancer	7.23e-06	0.000158	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BRIP1—breast cancer	7.23e-06	0.000158	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	7.12e-06	0.000156	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—SLC2A1—breast cancer	6.99e-06	0.000153	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NQO1—breast cancer	6.99e-06	0.000153	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP17A1—breast cancer	6.94e-06	0.000152	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS1—breast cancer	6.87e-06	0.00015	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ENO1—breast cancer	6.87e-06	0.00015	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA3—breast cancer	6.85e-06	0.00015	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMMR—breast cancer	6.85e-06	0.00015	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCC1—breast cancer	6.85e-06	0.00015	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.85e-06	0.00015	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP3A4—breast cancer	6.82e-06	0.000149	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.79e-06	0.000149	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP2D6—breast cancer	6.74e-06	0.000147	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1B1—breast cancer	6.71e-06	0.000147	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARGC1B—breast cancer	6.64e-06	0.000145	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOA2—breast cancer	6.61e-06	0.000145	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HSP90AA1—breast cancer	6.58e-06	0.000144	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	6.43e-06	0.000141	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—FASN—breast cancer	6.41e-06	0.00014	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOA1—breast cancer	6.4e-06	0.00014	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—BCHE—breast cancer	6.39e-06	0.00014	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC5A5—breast cancer	6.31e-06	0.000138	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP19A1—breast cancer	6.31e-06	0.000138	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—STK11—breast cancer	6.31e-06	0.000138	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA9—breast cancer	6.27e-06	0.000137	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA4—breast cancer	6.27e-06	0.000137	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA2—breast cancer	6.11e-06	0.000134	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPX2—breast cancer	6.11e-06	0.000134	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—SLC2A1—breast cancer	6.09e-06	0.000133	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NQO1—breast cancer	6.09e-06	0.000133	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPX4—breast cancer	6.03e-06	0.000132	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SULT1A1—breast cancer	6.03e-06	0.000132	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP3A4—breast cancer	5.94e-06	0.00013	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.92e-06	0.00013	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—IDH1—breast cancer	5.89e-06	0.000129	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTA1—breast cancer	5.89e-06	0.000129	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—COMT—breast cancer	5.86e-06	0.000128	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1B1—breast cancer	5.84e-06	0.000128	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTP1—breast cancer	5.83e-06	0.000128	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NAT2—breast cancer	5.83e-06	0.000128	CbGpPWpGaD
Sitagliptin—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.81e-06	0.000127	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—HMOX1—breast cancer	5.75e-06	0.000126	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ITPR1—breast cancer	5.74e-06	0.000126	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HSP90AA1—breast cancer	5.73e-06	0.000125	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOA1—breast cancer	5.57e-06	0.000122	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCB1—breast cancer	5.52e-06	0.000121	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—STK11—breast cancer	5.49e-06	0.00012	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP19A1—breast cancer	5.49e-06	0.00012	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMS—breast cancer	5.42e-06	0.000119	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GSTM1—breast cancer	5.36e-06	0.000117	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NCOR1—breast cancer	5.36e-06	0.000117	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PLA2G4A—breast cancer	5.36e-06	0.000117	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—GPX1—breast cancer	5.13e-06	0.000112	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—DPYD—breast cancer	5.11e-06	0.000112	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MED12—breast cancer	5.11e-06	0.000112	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—COMT—breast cancer	5.11e-06	0.000112	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTP1—breast cancer	5.08e-06	0.000111	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CYP1A1—breast cancer	5.08e-06	0.000111	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ERCC2—breast cancer	5.04e-06	0.00011	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALDOA—breast cancer	5.03e-06	0.00011	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—HMOX1—breast cancer	5.01e-06	0.00011	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ITPR1—breast cancer	5e-06	0.000109	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOA3—breast cancer	4.88e-06	0.000107	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC2A2—breast cancer	4.85e-06	0.000106	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CPT1A—breast cancer	4.75e-06	0.000104	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCG2—breast cancer	4.75e-06	0.000104	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTR—breast cancer	4.75e-06	0.000104	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—MTHFR—breast cancer	4.74e-06	0.000104	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMS—breast cancer	4.73e-06	0.000103	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GSTM1—breast cancer	4.67e-06	0.000102	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NCOR1—breast cancer	4.67e-06	0.000102	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PLA2G4A—breast cancer	4.67e-06	0.000102	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HPGDS—breast cancer	4.66e-06	0.000102	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HBA1—breast cancer	4.63e-06	0.000101	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTT1—breast cancer	4.52e-06	9.89e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ACHE—breast cancer	4.52e-06	9.89e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—GPX1—breast cancer	4.47e-06	9.79e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CYP1A1—breast cancer	4.43e-06	9.69e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ERCC2—breast cancer	4.39e-06	9.61e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CAV1—breast cancer	4.37e-06	9.56e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP17A1—breast cancer	4.28e-06	9.36e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS1—breast cancer	4.23e-06	9.26e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ENO1—breast cancer	4.23e-06	9.26e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.18e-06	9.14e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP2D6—breast cancer	4.15e-06	9.08e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—MTHFR—breast cancer	4.13e-06	9.03e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOA2—breast cancer	4.08e-06	8.92e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CG—breast cancer	3.98e-06	8.71e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—FASN—breast cancer	3.95e-06	8.65e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—BCHE—breast cancer	3.94e-06	8.61e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC5A5—breast cancer	3.89e-06	8.51e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CAV1—breast cancer	3.81e-06	8.33e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—SLC2A1—breast cancer	3.75e-06	8.22e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NQO1—breast cancer	3.75e-06	8.22e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1B1—breast cancer	3.6e-06	7.88e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.53e-06	7.72e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CD—breast cancer	3.5e-06	7.66e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CG—breast cancer	3.47e-06	7.59e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ALB—breast cancer	3.45e-06	7.56e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOA1—breast cancer	3.43e-06	7.51e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—STK11—breast cancer	3.38e-06	7.41e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP19A1—breast cancer	3.38e-06	7.41e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—NOS3—breast cancer	3.3e-06	7.23e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—COMT—breast cancer	3.15e-06	6.89e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTP1—breast cancer	3.13e-06	6.85e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—HMOX1—breast cancer	3.09e-06	6.76e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ITPR1—breast cancer	3.08e-06	6.74e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CB—breast cancer	3.05e-06	6.68e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CD—breast cancer	3.05e-06	6.67e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—breast cancer	3.02e-06	6.61e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ALB—breast cancer	3.01e-06	6.59e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCB1—breast cancer	2.96e-06	6.49e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMS—breast cancer	2.91e-06	6.37e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—NOS3—breast cancer	2.88e-06	6.3e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GSTM1—breast cancer	2.88e-06	6.3e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.88e-06	6.3e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NCOR1—breast cancer	2.88e-06	6.3e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—GPX1—breast cancer	2.76e-06	6.03e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CYP1A1—breast cancer	2.73e-06	5.97e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ERCC2—breast cancer	2.71e-06	5.92e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CB—breast cancer	2.66e-06	5.82e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTEN—breast cancer	2.64e-06	5.77e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—breast cancer	2.63e-06	5.76e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—MTHFR—breast cancer	2.54e-06	5.57e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CAV1—breast cancer	2.35e-06	5.13e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTEN—breast cancer	2.3e-06	5.03e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CG—breast cancer	2.14e-06	4.68e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CD—breast cancer	1.88e-06	4.11e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—breast cancer	1.86e-06	4.07e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ALB—breast cancer	1.85e-06	4.06e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—NOS3—breast cancer	1.77e-06	3.88e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CB—breast cancer	1.64e-06	3.58e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—breast cancer	1.62e-06	3.55e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—breast cancer	1.62e-06	3.55e-05	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—breast cancer	1.52e-06	3.32e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTEN—breast cancer	1.41e-06	3.1e-05	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—breast cancer	1.32e-06	2.9e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—breast cancer	9.98e-07	2.18e-05	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—breast cancer	8.15e-07	1.78e-05	CbGpPWpGaD
